Neuberger Berman Group »

Eledon Pharmaceuticals shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $52k 13k 3.94

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
State Street Corporation
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management

View all funds holding Eledon Pharmaceuticals